Біохімічні показники цереброспінальної рідини у хворих на гострий вірусний менінгіт та менінгоенцефаліт by Kozko, Volodymyr et al.
23 
Scientific Journal «ScienceRise: Medical Science» № 4(24)2018
1. Introduction
Neuroinfection is a worldwide problem, an im-
portant cause of morbidity and mortality in the world 
and in Ukraine [1, 2]. Viral infections are the main cause 
of meningitis and meningoencephalitis worldwide. They 
exceed the frequency of bacterial, fungal and protozoan 
neuroinfections [1]. At present believed that the etiology 
of viral defeat of the central nervous system (CNS) is 
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BIOCHEMICAL PARAMETERS OF CEREBROSPINAL FLUID IN PATIENTS WITH 
ACUTE VIRAL MENINGITIS AND MENINGOENCEPHALITIS
 © V. Kozko, A. Sokhan, Ya. Burma, A. Kuznietsova, A. Gavrylov 
Мета дослідження. Визначення діагностичної цінності вмісту лактату, лактатдегідрогенази, креати-
нінкінази, кислої фосфатази та холінестерази у ЦСР для ранньої діагностики та прогнозування перебігу 
гострого вірусного менінгіту та менінгоенцефаліту. 
Матеріали та методи. Було обстежено 92 пацієнта з підтвердженою вірусною етіологією захворю-
вання. Серед них – 20 хворих на ВПГ 1,2 нейроінфекцію, 19 хворих на ЕБВ нейроінфекцію, 15 з ВЗВ ней-
роінфекцією, 14 – з ВГЛ-6 нейроінфекцією і 24 пацієнта з ентеровірусним менінгітом. Пацієнти були 
розділені на групи в залежності від етіології та тяжкості хвороби. На додаток до аналізу клінічного 
перебігу захворювання, ми провели дослідження ЦСР хворих для визначення рівня креатинінкінази, лакта-
ту, лактатдегідрогенази, креатинінкінази, холінестерази та кислої фосфатази при стаціонарі та через 
10–12 днів лікування.
Результати дослідження. Найвищий середній вік спостерігався у пацієнтів з ВЗВ менінгітом – 38,27± 
±18,24 років, наймолодшими були пацієнти з ентеровірусною інфекцією – 24,05±5,72 (р˂0,001). Кількість 
жінок та чоловіків була однаковою практично у всіх групах, проте серед пацієнтів з ВПГ 1,2 нейроінфек-
цією жінки значно переважали – 16 (80 %) з 20 випадків. Найбільш тяжкий перебіг спостерігався у групах 
ЕБВ та ВГЛ-6 нейроінфекцій, де тяжкий перебіг спостерігався у 47,37 % та 35,71 % пацієнтів відповідно. 
Нейроінфекції ентеровірусної етіології мали найбільш сприятливий перебіг.
Отримані дані вказують на залежність рівнів показників, що досліджувались перш за все від тяжкості 
хвороби. Рівень креатинінкінази та кислотної фосфатази у пацієнтів з середньою тяжкістю був значно 
вищим порівняно з тяжкими пацієнтами (p<0,05). Рівень лактату був вищим у хворих з тяжкою нейро-
інфекцією (р<0,05). Найвищі рівні лактату визначались у хворих з ВГЛ-6 менінгоенцефалітом (р<0,05). 
Рівень холінестерази був достеменно нижчим у тяжких хворих. 
Висновки. Отримані результати підтверджують наявність глибоких метаболічних порушень у тканинах 
головного мозку у всіх хворих на гострі вірусні нейроінфекції як на початку хвороби так і в динаміці ліку-
вання. Визначення рівнів креатинінкінази, кислої фосфатази, лактату та холінестерази у ЦСР хворих на 
гострі вірусні нейроінфекції має високу діагностичну цінність, однак не можуть бути використані для 
прогнозу несприятливого перебігу хвороби
Ключові слова: цереброспінальна рідина, менінгіт, менінгоенцефаліт, кисла фосфатаза, креатинінкіназа, 
лактат, лактатдегідрогеназа, холінестераза
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most often due to enteroviruses, herpes viruses and some 
arboviruses. At the same time, 39 % of infections caused 
by these viruses lead to serious neurological disorders 
[1]. Herpesvirus neuroinfections are the most severe 
among the all viral lesion of the CNS, most often cause 
neurological disorders and have the highest mortality 
[2]. In connection with the morphological and functional 
features of the CNS, the diagnostics of meningitis and 
meningoencephalitis remains imperfect. At the present 
stage, only clinical and anamnestic indices, indicators 
of clinical analysis of cerebrospinal fluid (CSF) and, if 
there is such a possibility, data of magnetic resonance or 
computer tomography are used during work with patients 
with neuroinfection.
2. Case presentation
Viral infections of the CNS encompass both acute 
and chronic conditions caused by broad range of different 
pathogens. As a group, these diseases can have a complex 
and variable pathogenesis that is influenced by host, viral, 
and environmental factors [3]. Virus infection of the brain 
can cause severe and life-threatening disease [4]. The 
results of routine procedures to evaluate the CSF, e. g. 
pleocytosis and cytogram, protein, glucose and chloride 
concentrations seem not always to reflect the actual inten-
sity of the inflammatory process in the cerebral tissue in 
such conditions. As a result of viral damage to the menin-
ges and brain tissues, the permeability of the blood-brain 
barrier (BBB) is disrupted and metabolic disorders such 
as hypoxia, acidosis, oxidative stress develop. Such mul-
tifactorial disorders lead to cerebral edema, necrosis and 
apoptosis of brain cells [5]. Since prompt and precise etio-
logical diagnosis remains a challenge and often a thorough 
cerebrospinal fluid examination may not give a precise 
diagnosis, a quick and reliable test is required for rapid 
bedside diagnosis. Many enzymes are known to be present 
in abundance in the nervous system. Meningitis disturbs 
the BBB and is expected to cause rise in enzymatic ac-
tivity. Therefore, various investigators have used them for 
the diagnosis as well as for determining the prognosis in 
cases of meningitis [6]. However, the role of various CSF 
enzymes needs to be evaluated as not enough work has 
been carried out and majority of workers have estimated 
one of these enzymes either in CSF or serum. Furthermore, 
several advanced CSF parameters, such as CSF lactate, 
lactate dehydrogenase (LDG), creatinine kinase (CK), 
acid phosphatase (ACP) and cholinesterase (CHE), were 
not evaluated in series of patients with virus meningoen-
cephalitis in contrast to bacterial CNS infections where 
the beneficial contribution of the CSF has been established.
In this regard, studies aimed at determining the 
criteria for assessing the severity of the metabolic dis-
orders, forecasting and monitoring the effectiveness of 
treatment in a particular patient are becoming especially 
relevant. It may increase the effectiveness of treatment 
and reduces the severity of residual effects.
3. Purpose
The purpose of the study was to evaluate the diag-
nostic value of lactate, lactate dehydrogenase, creatinine 
kinase, acid phosphatase, and cholinesterase in the CSF 
for early diagnostics and prognostication of acute viral 
meningitis and meningoencephalitis.
4. Materials and methods
For the purpose of the study, a comprehensive ex-
amination of 453 patients with acute neuroinfection who 
were treated during 2010–2017 at the Regional Clinical 
Infectious Diseases Hospital (Kharkiv, Ukraine) was car-
ried out. The study was approved by the local Bioethics 
Committee of the National Medical University (Kharkiv, 
Ukraine). Inclusion of patients in the study was carried 
out in accordance with the selection criteria. Inclusion 
criteria: clinical symptoms typical for acute meningitis, 
etiological confirmation of the viral etiology of the dis-
ease, age of patients from 18 to 70 years, voluntary con-
sent of the patient to participate in the study. In patients 
with violations of consciousness or cognitive function 
during admission to a hospital, voluntary consent to par-
ticipate in the study was obtained after the normalization 
of the higher nervous activity function. Patients were 
excluded in the following cases: presence of diseases 
of the pituitary-adrenal system in history, HIV infec-
tion, neoplasms. The average age of the patients was 
33.54±2,76 years.
Etiology of neuroinfection was determined by 
PCR method of CSF. CSF was obtained by lumbar punc-
ture. The execution of lumbar puncture was performed in 
accordance with the local protocols of Regional Clinical 
Infectious Diseases Hospital and in accordance with the 
standards of medical care for patients with acute menin-
gitis and herpes virus neuroinfections of the Ministry of 
Health of Ukraine, № 487, 17.08.2007 About the approval 
of clinical protocols for the provision of medical care 
in the specialty “Neurology”. Patients who participated 
in the study were not subjected to additional invasive 
procedures.
We selected 92 patients with confirmed viral 
etiology of the disease. Among them – 20 patients with 
herpes simplex virus 1,2 types (HSV 1,2) infection, 
19 with Epstein Barr (EBV) infection, 15 with varicella 
zoster infection (VZV), 14 with human herpesvirus 
type 6 (HHV- 6) and 24 patients with enterovirus menin-
gitis. The patients were divided into groups depending on 
the etiology of neuroinfection. We also divided patients 
into subgroups of meningitis and meningoencephalitis. 
In addition to analyzing the clinical course of the 
disease, we performed the studies of patients CSF to 
determine the levels of CK, lactate, LDG, CK, CHE and 
ACP when inpatient and 10–12 days after treatment.
The levels of CK, LDG, CK, CHE and ACP were 
determined by the kinetic-photometric method using the 
diagnostic of the company “DAC-SpectroMed” (Moldo-
va); the level of lactate was determined by the enzymatic 
calorimetric method using a set of Olvex Diagnosticum 
(Russian Federation). The research was carried out in the 
Central Scientific Research Laboratory of the Kharkiv 
National Medical University.
The results are statistically processed using the 6th 
version of BiostatPro, AnalystSoft Inc. The verification 
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of the normality of the distribution of indicators in the 
samples was carried out using the Kolmogorov-Smirnov 
criterion. According to the size of the sample and the dis-
tribution of values, methods of non-parametric statistics 
were used (Mann-Whitney’s U-test). Indicators are given 
as Me (25, 75 %) (Median (25; 75 percentile)), and abso-
lute value (percent) (n %). The difference was considered 
probable at values p <0.05.
5. Results
The average age of patients with enterovirus 
meningitis was significantly lower than in groups with 
herpesvirus neuroinfections (p˂0.01). The highest age 
was observed in patients with VZV meningitis – 38.27± 
±18.24 years, the youngest – in patients with enterovirus 
meningitis – 24.05±5.72 (p˂0.001) (Mann-Whitney’s U- 
test). The quantity of women and men was the same al- 
most in all groups, however, among patients with HSV 1,2 
neuroinfection, women significantly predominated – 
16 (80 %) of 20 cases. The most severe was EBV and 
HHV-6 neuroinfection, a severe course of the disease 
was observed in 47.37 % and 35.71 % of patients (Table 1).
In all patients’ severity of the condition was 
caused by development of focal neurological symptoms 
and brain edema symptoms. In patients with EBV and 
HHV-6 neuroinfection, symptoms of focal lesions of the 
brain in the form of paresis, paralysis and cognitive im-
pairment were more common.
The disease of moderate severity was observed in 15 
(75 %) with HSV 1,2, 10 (52.63 %) with EBV, 11 (73.33 %) 
with VZV, 9 (64.29 %) with HHV-6 and 24 (100 %) with 
enterovirus etiology of the disease. The highest mortality 
was observed in patients with EBV (10.53 %) and HHV-6 
(7.14 %) neuroinfection (Table 1). 
The levels of CK, lactate, LDG, CK, CHE and 
ACP in the CSF of patients with medium severity course 
of virus neuroinfection on the first day of treatment are 
summarized in Table 2, in patients with severe course of 
disease – in Table 3.
In patients with viral meningitis in the dynamics 
of the disease their dependence on both the severity of 
the patient’s condition and the etiology of the disease was 
established in the study of CSF.
The levels of creatinine kinases, lactate, lactate 
dehydrogenase, cholinesterase and acid phosphatase in 
the CSF of patients with virus meningitis on the 10– 
12 day of treatment are summarized in Table 4, in pa-
tients with meningoencephalitis – in Table 5.
Table 1
General characteristics of patients depending on the etiology of the disease
Etiology of neuroinfection HSV 1,2 (n=20) EBV (n=19) VZV (n=15) HHV–6 (n=14) Enterovirus (n=24)
Age of patients 
(Mean±SD)
35.5±14.7 36.4±16.1 38.3±18.2 31.7±13.0 24.1±5.7
Men, n/% 4/20.0 7/36.8 9/60.0 8/57.1 13/54.2
Women, n/% 16/80.0 12/63.2 6/40.0 6/42.9 11/45.8
Meningitis, n/% 15/75.0 10/52.6 11/73.3 9/64.3 24/10
Meningoencephalitis, n/% 5/25.0 9/47.4 4/26.7 5/35.7 0/
Lethal outcome, n/% 1/5.0 2/10.5 1/6.7 1/7.1 0/
Table 2
Level of CK, lactate, LDG, CK, CHE and ACP in CSF of patients with moderate severity on the first day of  
treatment, Me (Q25: Q75)
Etiology CK, (U/l) ACP, (U/l) Lactate, (mmol/l) LDG, (U/l) CHE, (U/l)
HSV (n=15) 3.64 (1.97:4.05) 0.73 (0.67:0.96) 2.05 (1.76:2.43) 28.04 (26.10:30.54) 187.57 (143.64:201.42)
EBV (n=10) 5.15 (2.78:6.89) 0.92 (0.83:1.31) 1.41 (1.05:1.76) 20.36 (14.46:25.54) 104.68 (93.32:131.05)
VZV (n=11) 3.24 (3.04:3.67) 0.76 (0.52:1.04) 1.91 (1.52:2.52) 23.65 (18.22:31.45) 138.47 (110.14:198.35)
HHV-6 (n=9) 4.52 (3.82:5.17) 0.78 (0.74:0.85) 3.09 (2.71:3.50) 24.90 (21.98:30.05) 168.57 (139.86:204.12)
Enterovirus (n=24) 3.55 (1.46:4.25) 0.59 (0.45:0.76) 1.17 (1.08:1.72) 13.08 (11.83:16.32) 82.74 (79.53:86.59)
Table 3
Level of CK, ACP, lactate, LDG, CHE in CSF of patients with severe course on the first day of treatment, Me (Q25: Q75)
Etiology CK, (U/l) ACP, (U/l) Lactate, (mmol/l) LDG, (U/l) CHE, (U/l)
HSV (n=5) 1.05 (0.98:1.32) 0.30 (0.21:0.47) 2.76 (2.25:2.89) 30.56 (28.47:31.74) 254.52 (204.31:276.65)
EBV (n=9) 2.64 (1.78:4.86) 0.38 (0.23:0.49) 3.03 (2.67:3.89) 22.66 (14.65:27.92) 121.87 (111.12:124.76)
HHV-6 (n=5) 4.17 (4.05:6.48) 0.75 (0.65:0.79) 3.83 (3.42:4.29) 19.54 (16.84:20.69) 122.63 (121.64:127.07)
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In the dynamics of the disease, at 10–12 days of 
treatment and improvement of the patients, decreased 
levels of CK (p<0.05), increase in cholinesterase ac-
tivity in severe patients to indicators of moderate se-
verity (p<0.001), decrease in lactate level, which in 
meningoencephalitis all one remained significantly 
higher than meningitis (p<0.05), decreased of lactate 
dehydrogenase activity (p<0.05) were observed. The 
level of cholinesterase had a multi-directional pattern – 
in patients with HSV, it decreased (p<0.001), while in 
other groups it increased or remained without signifi-
cant changes. 
6. Discussion
The level of creatinine kinase and acid phospha-
tase in patients with moderate severity was significantly 
higher in comparison with severe patients (p <0.05). 
Lower activity of creatinine kinase in patients with 
meningoencephalitis in comparison with meningitis is 
unexpected, given that in bacterial neuroinfections, the 
activity of total creatinine kinase increases directly pro-
portional to the severity of the disease [7].
The level of lactate was higher in patients with 
severe neuroinfection (p<0.05). The level of lactate in 
CSF reflects the degree of hypoxic-ischemic disorders 
of the brain tissues. For viral neuroinfections, changes 
in lactate levels are negligible and almost never reaches 
values above 3 mmol/l [8], however, these investigations 
did not examine patients with HHV-6 infection. Our re-
sults indicate that in patients with HHV-6 neuroinfection, 
the level of lactate is significantly higher in comparison 
with other viral neuroinfections (p<0.001) (Table 2, 3). At 
the same time, lactate dehydrogenase levels did not have 
differences depending on severity, but were significantly 
higher in individuals with HSV neuroinfection compared 
to all other groups of viral meningitis (p<0.05).
Lowest cholinesterase levels were observed 
in patients with enteroviral meningitis (p<0.001). In 
groups with EBV, VZV, HHV-6 neuroinfection, the 
level of cholinesterase was significantly lower than with 
HSV-neuroinfection. It also significantly decreased in 
patients with severe EBV and HHV-6, while in patients 
with severe course of HSV significant increase of cho-
linesterase was observed in compared to patients with 
moderate severity (p<0.05) (Table 2, 3). Сholinesterase 
is involved in the transmission of nerve impulses. It is 
supposed that cholinesterase hydrolyzes acetylcholine 
in the neuromuscular compounds and thus protects 
them from acetylcholine excess [9, 10]. In addition, 
cholinesterase is able to hydrolyze many toxic organo-
phosphorus substances. It has been established that the 
introduction into the animal’s blood of serum cholines-
terase of a horse or recombinant human cholinesterase 
protects them from lethal doses of organophosphorus 
compounds by 100 % [10]. It is assumed that it controls 
the permeability of cell membranes and vessel walls. 
There is high probability of enzyme involvement in the 
formation of neuropeptides, since in the cholinesterase 
molecule not only the esterase, but also the peptidase 
active center is localized [9, 10].
Thus, an increase of cholinesterase activity in the 
acute period of neuroinfection, rather, is a sanogenetic 
reaction to the emerging pathological processes. The low 
activity of cholinesterase in patients with meningoen-
cephalitis reflects a breakdown of adaptation and possi-
bly leads to the accumulation of toxins and acetylcholine 
in the tissues of the CNS, which contributes to the de-
velopment of disorders of nerve impulses transmission, 
brain edema, and necrotic changes in the CNS.
The presence of metabolic changes in CSF in 
patients on the 10–12 days of treatment indicates about 
presence of pathological process in brain tissues longer 
than the clinical symptoms of the disease. Such results 
also reflect the differences in the pathogenesis of neu-
roinfection caused by different viruses and the different 
efficacy of their therapy.
Table 4
Level of CK, ACP, lactate, LDG, CHE in CSF in patients with moderate severity for 10-12 days of treatment, Me (Q25: 
Q75)
Etiology CK, (U/l) ACP, (U/l) Lactate, (mmol/l) LDG, (U/l) CHE, (U/l)
HSV (n=15) 2.05 (1.68:3.01) 0.75 (0.33:0.84) 1.33 (0.98:1.67) 18.46 (14.46:20.74) 112.52 (98.42:132.63)
EBV (n=10) 3.48 (2.42:4.65) 0.63 (0.53:0.94) 1.04 (0.87:1.25) 20.55 (17.92:27.08) 159.62 (107.19:183.81)
VZV (n=11) 1.76 (1.54:2.52) 0.59 (0.45:0.83) 1.14 (0.95:1.77) 13.52 (12.86:20.12) 143.47 (86.35:204.14)
HHV-6 (n=9) 1.37 (1.02:2.02) 0.79 (0.75:0.82) 0.99 (0.71:1.35) 14.34 (11.73:16.61) 166.49 (104.50:194.64)
Enterovirus (n=24) 4.75 (3.16:5.02) 0.60 (0.55:0.83) 1.17 (0.95:1.22) 13.54 (10.06:18.75) 77.26 (73.15:80.94)
Table 5
Level of CK, ACP, lactate, LDG, CHE in CSF of patients with severe course on 12 days of treatment, Me (Q25: Q75)
Etiology CK, (U/l) ACP, (U/l) Lactate, (mmol/l) LDG, (U/l) CHE, (U/l)
HSV (n=5) 1.25 (0.98:1.67) 0.64 (0.48:0.76) 1.56 (0.95:1.67) 19.47 (18.74:19.57) 143.86 (123.53:156.36)
EBV (n=9) 1.45 (1.08:2.82) 0.71 (0.53:0.79) 1.54 (1.37:2.20) 25.24 (19.07:30.33) 115.87 (101.39:119.41)
HHV-6 (n=5) 4.09 (2.17:6.35) 0.31 (0.29:0.87) 1.32 (0.94:1.41) 16.36 (11.53:20.53) 99.41 (95.55:115.52)
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7. Conclusions
1. The obtained results indicate about presence of 
statistically significant difference in levels of CK, ACP, 
lactate, LDG and CHE in CSF in patients with acute viral 
neuroinfections in the acute period of the disease.
2. These parameters can be taken into diagnostics 
and research of viral neuroinfections pathogenesis. 
3. Assessment of biochemical parameters of CSF 
can be used in assessing of the disease severity and ef-
fectiveness of the treatment. 
4. The indicators of creatinine kinase, lactate and 
cholinesterase have the greatest diagnostic value on the 
first day of treatment of patients.
5. Neuroinfections of enterovirus etiology are 
characterized by the least severe course of the disease. 
In the group of enterovirus neuroinfections, the least 
pronounced changes in biochemical parameters in CSF 
were revealed.
6. The development of meningoencephalitis is 
accompanied by deeper changes in biochemical parame-
ters, which reflects the failure of the adaptation of com-
pensatory and adaptive responses and can be used in the 
diagnosis and treatment of patients.
7. The presence of metabolic changes in CSF in 
patients with HSV, EBV, and HHV-6 infection on 10–12 
days of treatment indicates the presence of a pathological 
process in brain tissues longer than observed clinical 
symptoms of the disease and reflects the difference in 
the pathogenesis and the effectiveness of treatment of 
various viral neuroinfections.
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